RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Book Review: Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

Book Review: Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

Posted 01 June 2011 | By Robert Schiff, PhD, RAC, CQA, FRAPS

As part of the Princeton Studies in American Politics series, Daniel Carpenter has written one of the most insightful and comprehensive treatments of drug regulation in the US.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.